Jared P Reis1, Erin D Michos2, Elizabeth Selvin2, James S Pankow2, Pamela L Lutsey2. 1. From the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (JPR); the Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (EDM); the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (ES); and the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (JSP and PLL). reisjp@mail.nih.gov. 2. From the Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, Bethesda, MD (JPR); the Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (EDM); the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (ES); and the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN (JSP and PLL).
Abstract
BACKGROUND: Low 25-hydroxyvitamin D [25(OH)D] is associated with diabetes, but few studies have examined racially diverse populations while also accounting for key vitamin D-binding protein (DBP) gene polymorphisms. OBJECTIVE: We sought to evaluate whether the association between 25(OH)D and incident diabetes varied by race and important DBP single nucleotide polymorphisms (SNPs). DESIGN: We studied 10,222 adults (8120 whites, 2102 blacks) aged 46-70 y at baseline (1990-1992) from the ARIC (Atherosclerosis Risk in Communities) Study with follow-up for incident diabetes ascertained during study visits conducted in 1993-1995 and 1996-1998. Adjusted HRs and their 95% CIs for diabetes were estimated according to 25(OH)D status. RESULTS: During follow-up there were 750 incident cases of diabetes. The association of 25(OH)D with diabetes varied by race (P-interaction = 0.004). Among whites, the adjusted HR for diabetes corresponding to each additional SD higher 25(OH)D concentration (21.3 nmol/L) was 0.95 (95% CI: 0.91, 0.99). No significant association was observed among blacks (HR: 1.06; 95% CI: 0.99, 1.14). There was evidence that the A allele at rs4588 and the T allele at rs7041, which are reported to be associated with high and low DBP concentrations, respectively, modified the association between 25(OH)D and diabetes among whites (P-interaction < 0.05 for both) but not blacks (P-interaction > 0.50 for both). CONCLUSIONS: In this large, community-based study, low 25(OH)D concentrations were associated with diabetes among whites but not blacks. Interactions by key DBP SNPs varied between genotypes associated with either high or low DBP concentrations among whites but not blacks. Nevertheless, the findings from this prospective study suggest that there are important differences in the association of 25(OH)D with incident diabetes between white and black adults.
BACKGROUND: Low 25-hydroxyvitamin D [25(OH)D] is associated with diabetes, but few studies have examined racially diverse populations while also accounting for key vitamin D-binding protein (DBP) gene polymorphisms. OBJECTIVE: We sought to evaluate whether the association between 25(OH)D and incident diabetes varied by race and important DBP single nucleotide polymorphisms (SNPs). DESIGN: We studied 10,222 adults (8120 whites, 2102 blacks) aged 46-70 y at baseline (1990-1992) from the ARIC (Atherosclerosis Risk in Communities) Study with follow-up for incident diabetes ascertained during study visits conducted in 1993-1995 and 1996-1998. Adjusted HRs and their 95% CIs for diabetes were estimated according to 25(OH)D status. RESULTS: During follow-up there were 750 incident cases of diabetes. The association of 25(OH)D with diabetes varied by race (P-interaction = 0.004). Among whites, the adjusted HR for diabetes corresponding to each additional SD higher 25(OH)D concentration (21.3 nmol/L) was 0.95 (95% CI: 0.91, 0.99). No significant association was observed among blacks (HR: 1.06; 95% CI: 0.99, 1.14). There was evidence that the A allele at rs4588 and the T allele at rs7041, which are reported to be associated with high and low DBP concentrations, respectively, modified the association between 25(OH)D and diabetes among whites (P-interaction < 0.05 for both) but not blacks (P-interaction > 0.50 for both). CONCLUSIONS: In this large, community-based study, low 25(OH)D concentrations were associated with diabetes among whites but not blacks. Interactions by key DBP SNPs varied between genotypes associated with either high or low DBP concentrations among whites but not blacks. Nevertheless, the findings from this prospective study suggest that there are important differences in the association of 25(OH)D with incident diabetes between white and black adults.
Authors: M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt Journal: Diabetes Care Date: 1998-04 Impact factor: 19.112
Authors: F Cosman; D C Morgan; J W Nieves; V Shen; M M Luckey; D W Dempster; R Lindsay; M Parisien Journal: J Bone Miner Res Date: 1997-06 Impact factor: 6.741
Authors: Kiran Musunuru; Guillaume Lettre; Taylor Young; Deborah N Farlow; James P Pirruccello; Kenechi G Ejebe; Brendan J Keating; Qiong Yang; Ming-Huei Chen; Nina Lapchyk; Andrew Crenshaw; Liuda Ziaugra; Anthony Rachupka; Emelia J Benjamin; L Adrienne Cupples; Myriam Fornage; Ervin R Fox; Susan R Heckbert; Joel N Hirschhorn; Christopher Newton-Cheh; Marcia M Nizzari; Dina N Paltoo; George J Papanicolaou; Sanjay R Patel; Bruce M Psaty; Daniel J Rader; Susan Redline; Stephen S Rich; Jerome I Rotter; Herman A Taylor; Russell P Tracy; Ramachandran S Vasan; James G Wilson; Sekar Kathiresan; Richard R Fabsitz; Eric Boerwinkle; Stacey B Gabriel Journal: Circ Cardiovasc Genet Date: 2010-04-17
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Ian H de Boer; Lesley F Tinker; Stephanie Connelly; J David Curb; Barbara V Howard; Bryan Kestenbaum; Joseph C Larson; JoAnn E Manson; Karen L Margolis; David S Siscovick; Noel S Weiss Journal: Diabetes Care Date: 2008-01-30 Impact factor: 19.112
Authors: Kendra A Young; Corinne D Engelman; Carl D Langefeld; Kristen G Hairston; Steven M Haffner; Michael Bryer-Ash; Jill M Norris Journal: J Clin Endocrinol Metab Date: 2009-06-23 Impact factor: 5.958
Authors: Di Zhao; Pamela Ouyang; Ian H de Boer; Pamela L Lutsey; Youssef M K Farag; Eliseo Guallar; David S Siscovick; Wendy S Post; Rita R Kalyani; Kevin L Billups; Erin D Michos Journal: Maturitas Date: 2016-11-29 Impact factor: 4.342
Authors: Adrienne Tin; Long Zhang; Michelle M Estrella; Andy Hoofnagle; Casey M Rebholz; Todd T Brown; Frank J Palella; Mallory D Witt; Lisa P Jacobson; Lawrence A Kingsley; Alison G Abraham Journal: AIDS Res Hum Retroviruses Date: 2017-09-05 Impact factor: 2.205
Authors: Erin D Michos; Jeffrey R Misialek; Elizabeth Selvin; Aaron R Folsom; James S Pankow; Wendy S Post; Pamela L Lutsey Journal: Atherosclerosis Date: 2015-04-25 Impact factor: 5.162
Authors: David C Gibbs; Veronika Fedirko; Caroline Um; Myron D Gross; Bharat Thyagarajan; Roberd M Bostick Journal: Am J Epidemiol Date: 2018-09-01 Impact factor: 4.897
Authors: Youssef M K Farag; Eliseo Guallar; Di Zhao; Rita R Kalyani; Michael J Blaha; David I Feldman; Seth S Martin; Pamela L Lutsey; Kevin L Billups; Erin D Michos Journal: Atherosclerosis Date: 2016-07-29 Impact factor: 5.162
Authors: Kathleen M Hill Gallant; Connie M Weaver; Dwight A Towler; Sowmyanarayanan V Thuppal; Regan L Bailey Journal: Adv Nutr Date: 2016-05-16 Impact factor: 8.701